Addition of Cyclophosphamide and Higher Doses of Dexamethasone Do Not Improve Outcomes of Patients With AL Amyloidosis Treated With Bortezomib

Clinical Lymphoma, Myeloma and Leukemia - United States
doi 10.1016/j.clml.2017.03.119

Related search